FDA Inspection 1022663 — American Red Cross Blood Services

American Red Cross Blood Services — FEI 1276530

The FDA completed an inspection of American Red Cross Blood Services on July 14, 2017 in Bangor, ME. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 14, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bangor, ME (United States)